Cleared Traditional

K833303 - DUOFLO 6F

K833303 is an FDA 510(k) clearance for DUOFLO 6F, manufactured by Argon Medical Corp.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 95-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1983
Decision
95d
Days
Class 2
Risk

K833303 is an FDA 510(k) clearance for the DUOFLO 6F. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Argon Medical Corp. (Mchenry, US). The FDA issued a Cleared decision on December 27, 1983 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Argon Medical Corp. devices

FDA 510(k) Submission Details - K833303

510(k) Number K833303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 1983
Decision Date December 27, 1983
Days to Decision 95 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 125d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 791
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K833303.
RADIOPAQUE 7 FRX 12-POLYURETHANE MULTI
K840336 · Arrow Intl., Inc. · Feb 1984
DOUBLE LUMEN INFUSION CATHETERS
K840175 · Medical Components, Inc. · Feb 1984
MAHURKAR DUAL LIMEN FEMORAL CATHETER
K834109 · Quinton, Inc. · Feb 1984
ULTRA LIGHT RAAF CATHETER
K832784 · Quinton, Inc. · Oct 1983
AMPLATZ HEPARIN COATED CATHETER
K832178 · Cook, Inc. · Aug 1983
PERCUTANEOUS CATHETER INSERTION TRAY
K831729 · American Pharmaseal Div. Ahsc · Jul 1983